(Q54450912)

English

Homoharringtonine: an effective new drug for remission induction in refractory nonlymphoblastic leukemia.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3889229

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3889229

title

Homoharringtonine: an effective new drug for remission induction in refractory nonlymphoblastic leukemia. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3889229

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3889229

1 reference

R P Warrell

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3889229

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3889229

C J Coonley

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3889229

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3889229

T S Gee

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3889229

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3889229

language of work or name

English

0 references

publication date

1 May 1985

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3889229

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3889229

published in

Journal of Clinical Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3889229

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3889229

volume

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3889229

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3889229

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3889229

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3889229

page(s)

617-621

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3889229

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3889229

Identifiers

DOI

10.1200/JCO.1985.3.5.617

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3889229

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3889229

PubMed publication ID

3889229

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3889229

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3889229

(Q54450912)

Homoharringtonine: an effective new drug for remission induction in refractory nonlymphoblastic leukemia.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)